Sarah E. Wilson

3.7k total citations · 3 hit papers
79 papers, 1.7k citations indexed

About

Sarah E. Wilson is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Sarah E. Wilson has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Health and 32 papers in Infectious Diseases. Recurrent topics in Sarah E. Wilson's work include Vaccine Coverage and Hesitancy (38 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Virology and Viral Diseases (12 papers). Sarah E. Wilson is often cited by papers focused on Vaccine Coverage and Hesitancy (38 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Virology and Viral Diseases (12 papers). Sarah E. Wilson collaborates with scholars based in Canada, United States and United Kingdom. Sarah E. Wilson's co-authors include Shelley L. Deeks, Jeffrey C. Kwong, Sarah A. Buchan, Aleksander Hinek, Sharifa Nasreen, Kumanan Wilson, Natasha S. Crowcroft, Kevin L. Schwartz, Jonathan B. Gubbay and Kevin A. Brown and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sarah E. Wilson

73 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes

2022 194 citations Sarah A. Buchan, Hannah Chung et al. profile →
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

2022 170 citations Sharifa Nasreen, Hannah Chung et al. Nature Microbiology profile →
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada

2022 102 citations Sarah A. Buchan, Caitlin Johnson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah E. Wilson Canada	23	851	671	577	179	135	79	1.7k
Sarah Mbaeyi United States	15	655 0.8×	662 1.0×	725 1.3×	139 0.8×	178 1.3×	32	1.7k
Nancy McClung United States	12	801 0.9×	694 1.0×	280 0.5×	305 1.7×	162 1.2×	16	1.6k
Katia Bruxvoort United States	24	766 0.9×	328 0.5×	491 0.9×	121 0.7×	65 0.5×	106	1.9k
Bradley K. Ackerson United States	26	2.1k 2.5×	929 1.4×	1.1k 1.9×	396 2.2×	222 1.6×	100	3.4k
Hongxing Pan China	13	1.4k 1.6×	501 0.7×	416 0.7×	157 0.9×	91 0.7×	39	1.8k
Nicolás Dauby Belgium	20	720 0.8×	376 0.6×	499 0.9×	143 0.8×	88 0.7×	101	1.6k
Danielle Moulia United States	16	788 0.9×	424 0.6×	355 0.6×	123 0.7×	213 1.6×	31	1.4k
Paige Marquez United States	23	1.1k 1.3×	630 0.9×	298 0.5×	95 0.5×	431 3.2×	58	1.8k
Chantal Sauvageau Canada	23	510 0.6×	824 1.2×	1.3k 2.2×	104 0.6×	279 2.1×	89	1.9k
Sara E. Oliver United States	20	1.6k 1.9×	1.0k 1.5×	677 1.2×	384 2.1×	378 2.8×	54	2.9k

Countries citing papers authored by Sarah E. Wilson

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Wilson more than expected).

Fields of papers citing papers by Sarah E. Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Wilson. The network helps show where Sarah E. Wilson may publish in the future.

Co-authorship network of co-authors of Sarah E. Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Wilson. A scholar is included among the top collaborators of Sarah E. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Wilson. Sarah E. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Senthinathan, Arrani, Vinita Dubey, Milena Forte, et al.. (2025). Impact of the COVID-19 pandemic on routine immunization coverage of children and teenagers in Ontario, Canada. Vaccine. 49. 126811–126811. 1 indexed citations

Top, Karina A., Julie A. Bettinger, Joanne E. Embree, et al.. (2025). Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive Study. The Journal of Pediatrics. 284. 114642–114642. 1 indexed citations

Naveed, Zaeema, Cherry Chu, Mina Tadrous, et al.. (2024). A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection. Heliyon. 10(5). e26551–e26551. 2 indexed citations

Muller, Matthew, Christine Navarro, Sarah E. Wilson, et al.. (2024). Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study. Vaccine. 42(3). 535–540. 7 indexed citations

Lee, Nelson, Lena Nguyen, Peter C. Austin, et al.. (2023). Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults. Clinical Infectious Diseases. 78(5). 1372–1382. 4 indexed citations

Grewal, Ramandip, Lena Nguyen, Sarah A. Buchan, et al.. (2023). Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nature Communications. 14(1). 1273–1273. 32 indexed citations

Nasreen, Sharifa, Jun Wang, Manish Sadarangani, et al.. (2022). Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005–2018: a Canadian Immunisation Research Network (CIRN) study. BMJ Open Respiratory Research. 9(1). e001218–e001218. 9 indexed citations

Wilson, Sarah E., Samantha B. Meyer, Devon Greyson, et al.. (2022). “We need to protect each other”: COVID-19 vaccination intentions and concerns among Racialized minority and Indigenous Peoples in Canada. Social Science & Medicine. 313. 115400–115400. 22 indexed citations

Nasreen, Sharifa, Hannah Chung, Siyi He, et al.. (2022). Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nature Microbiology. 7(3). 379–385. 170 indexed citations breakdown →

10.

Dubé, Ève, S. Michelle Driedger, Janice Graham, et al.. (2022). “ I don’t think there’s a point for me to discuss it with my patients” : exploring health care providers’ views and behaviours regarding COVID-19 vaccination. Human Vaccines & Immunotherapeutics. 18(5). 2088970–2088970. 8 indexed citations

11.

Chung, Hannah, Peter C. Austin, Kevin A. Brown, et al.. (2022). Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study. Open Forum Infectious Diseases. 9(9). ofac449–ofac449. 10 indexed citations

12.

Paul, Lauren A., Nick Daneman, Kevin A. Brown, et al.. (2021). Characteristics Associated With Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Ontario, Canada: A Cohort Study. Clinical Infectious Diseases. 73(10). 1840–1848. 17 indexed citations

13.

Nasreen, Sharifa, Andrew Calzavara, Maria E. Sundaram, et al.. (2021). Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study. BMJ Open. 11(12). e052019–e052019. 6 indexed citations

14.

Sundaram, Maria E., Sharifa Nasreen, Andrew Calzavara, et al.. (2021). Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments. Vaccine. 39(37). 5265–5270. 5 indexed citations

15.

Righolt, Christiaan H., Jessy Donelle, Paula Brna, et al.. (2021). Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study. Vaccine. 39(15). 2117–2123. 3 indexed citations

16.

Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2019). Equity and impact: Ontario’s infant rotavirus immunization program five years following implementation. A population-based cohort study. Vaccine. 37(17). 2408–2414. 7 indexed citations

17.

Bolotin, Shelly, Alberto Severini, Todd F. Hatchette, et al.. (2019). Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study. Human Vaccines & Immunotherapeutics. 15(12). 2856–2864. 12 indexed citations

18.

Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2016). Population-Level Impact of Ontario’s Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects. PLoS ONE. 11(5). e0154340–e0154340. 26 indexed citations

19.

Wilson, Sarah E., Susan Quach, Shannon E. MacDonald, et al.. (2016). Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network study. Canadian Journal of Public Health. 107(6). e575–e582. 20 indexed citations

20.

Wilson, Sarah E., et al.. (2012). Ontario’s School-based HPV Immunization Program: School Board Assent and Parental Consent. Canadian Journal of Public Health. 103(1). 34–39. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact